| COVID-19 and healthcare impacts | Lifetime | 13 | JP 1 | 99.49 |
| Infection Control and Ventilation | Lifetime | 9 | JP 1 | 99.52 |
| Vaccine Coverage and Hesitancy | Lifetime | 28 | JP 1 | 99.54 |
| COVID-19 epidemiological studies | Lifetime | 32 | JP 1 | 99.54 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 190 | JP 2 | 99.18 |
| Influenza Virus Research Studies | Lifetime | 94 | JP 3 | 99.36 |
| Viral Infections and Outbreaks Research | Lifetime | 49 | JP 3 | 99.28 |
| COVID-19 and Mental Health | Lifetime | 156 | JP 3 | 98.35 |
| Data-Driven Disease Surveillance | Lifetime | 34 | JP 1 | 98.33 |
| Respiratory viral infections research | Lifetime | 307 | JP 5 | 98.73 |
| Infection Control in Healthcare | Lifetime | 35 | JP 1 | 98.86 |
| Pneumonia and Respiratory Infections | Lifetime | 335 | JP 2 | 98.79 |
| COVID-19 Clinical Research Studies | Lifetime | 727 | JP 11 | 97.44 |
| Bacillus and Francisella bacterial research | Lifetime | 113 | JP 1 | 97.68 |
| COVID-19 Pandemic Impacts | Lifetime | 135 | JP 4 | 96.55 |
| Disaster Response and Management | Lifetime | 236 | JP 3 | 97.10 |
| Travel-related health issues | Lifetime | 76 | JP 1 | 96.97 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 285 | JP 15 | 97.31 |
| Bacterial Infections and Vaccines | Lifetime | 437 | JP 5 | 96.65 |
| Zoonotic diseases and public health | Lifetime | 376 | JP 2 | 95.23 |
| Poxvirus research and outbreaks | Lifetime | 239 | JP 4 | 95.36 |
| Misinformation and Its Impacts | Lifetime | 905 | JP 6 | 89.12 |
| Medical Coding and Health Information | Lifetime | 450 | JP 3 | 78.35 |
| Bartonella species infections research | Lifetime | 612 | JP 20 | 74.58 |
| COVID-19 and healthcare impacts | 2021-2025 | 17 | JP 1 | 99.19 |
| COVID-19 epidemiological studies | 2021-2025 | 32 | JP 2 | 99.10 |
| Infection Control and Ventilation | 2021-2025 | 11 | JP 1 | 99.08 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 52 | JP 1 | 98.75 |
| Influenza Virus Research Studies | 2021-2025 | 43 | JP 1 | 98.19 |
| Data-Driven Disease Surveillance | 2021-2025 | 12 | JP 1 | 96.96 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 380 | JP 5 | 98.37 |
| Viral Infections and Outbreaks Research | 2021-2025 | 79 | JP 2 | 95.31 |
| Poxvirus research and outbreaks | 2021-2025 | 156 | JP 1 | 88.81 |
| Bacillus and Francisella bacterial research | 2021-2025 | 177 | JP 3 | 86.25 |
| Zoonotic diseases and public health | 2021-2025 | 355 | JP 2 | 85.20 |
| Bacterial Infections and Vaccines | 2021-2025 | 756 | JP 26 | 73.53 |
